The ROE as of September 2024 (TTM) for Catalyst Pharmaceuticals, Inc. (CPRX) is 14.30%

According to Catalyst Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 14.30%. This represents a change of 419.70% compared to the average of 2.75% of the last 4 quarters.

Catalyst Pharmaceuticals, Inc. (CPRX) Historical ROE (quarterly & annually)

How has CPRX ROE performed in the past?

The mean historical ROE of Catalyst Pharmaceuticals, Inc. over the last ten years is -7.04%. The current 14.30% ROE has changed -303.07% with respect to the historical average. Over the past ten years (40 quarters), CPRX's ROE was at its highest in in the September 2020 quarter at 27.67%. The ROE was at its lowest in in the December 2018 quarter at -28.55%.

Catalyst Pharmaceuticals, Inc. (CPRX) ROE by Quarter and Year

Discovering the peaks and valleys of Catalyst Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Catalyst Pharmaceuticals, Inc. (CPRX) Average ROE

How has CPRX ROE performed in the past?

The current ROE of Catalyst Pharmaceuticals, Inc. (CPRX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Catalyst Pharmaceuticals, Inc. (CPRX) ROE vs. Peers

How is CPRX’s ROE compared to its peers?

Catalyst Pharmaceuticals, Inc.’s ROE is greater than Day One Biopharmaceuticals, Inc. (-122.70%), greater than Terns Pharmaceuticals, Inc. (-39.58%), less than X4 Pharmaceuticals, Inc. (32.93%), greater than Inozyme Pharma, Inc. (-68.93%), greater than Mereo BioPharma Group plc (-63.39%), less than Exelixis, Inc. (15.80%), greater than TG Therapeutics, Inc. (-38.21%), greater than Viking Therapeutics, Inc. (-15.05%), greater than Madrigal Pharmaceuticals, Inc. (-95.61%), less than BioXcel Therapeutics, Inc. (176.93%), greater than Axsome Therapeutics, Inc. (-174.48%), less than Incyte Corporation (2.10%), greater than ImmunoGen, Inc. (-21.97%), less than Sarepta Therapeutics, Inc. (5.17%), less than ACADIA Pharmaceuticals Inc. (6.89%), greater than Intercept Pharmaceuticals, Inc. (-78.24%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), greater than Akero Therapeutics, Inc. (-29.56%), less than Reata Pharmaceuticals, Inc. (19.32%),

Build a custom stock screener for Catalyst Pharmaceuticals, Inc. (CPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Catalyst Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Catalyst Pharmaceuticals, Inc. (CPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Catalyst Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.